- Sections
- C - Chimie; métallurgie
- C07D - Composés hétérocycliques
- C07D 333/40 - Acide thiophène-2-carboxylique
Détention brevets de la classe C07D 333/40
Brevets de cette classe: 170
Historique des publications depuis 10 ans
17
|
12
|
10
|
7
|
9
|
11
|
4
|
6
|
9
|
0
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Allergan, Inc. | 2600 |
27 |
Takeda Pharmaceutical Company Limited | 2961 |
11 |
Astellas Pharma Inc. | 1145 |
9 |
Vertex Pharmaceuticals Incorporated | 1581 |
8 |
Theravance Biopharma R&D IP, LLC | 550 |
6 |
Nitto Denko Corporation | 7879 |
5 |
Aerie Pharmaceuticals, Inc. | 131 |
5 |
EA Pharma Co., Ltd. | 77 |
5 |
Ishihara Sangyo Kaisha, Ltd. | 663 |
5 |
Bayer AG | 3045 |
4 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 762 |
4 |
Northwestern University | 3112 |
3 |
Metabrain Research | 12 |
3 |
Sumitomo Chemical Company, Limited | 8808 |
2 |
Millennium Pharmaceuticals, Inc. | 488 |
2 |
Virochem Pharma Inc. | 11 |
2 |
ASKA Pharmaceutical Co., Ltd. | 104 |
2 |
Daiichi Sankyo Company, Limited | 1829 |
2 |
Iowa State University Research Foundation, Inc. | 685 |
2 |
Research Foundation Itsuu Laboratory | 12 |
2 |
Autres propriétaires | 61 |